A novel needle for subcutaneous injection of interferon beta-1a: Effect on pain in volunteers and satisfaction in patients with multiple sclerosis

BMC Neurology

Volumn 8, Issue , 2008, Pages

  Jaber, Amer ^a,d   Bozzato, Gian B ^a   Vedrine, Lionel ^b   Prais, Wes A ^b   Berube, Julie ^b   Laurent, Philippe E ^c  

^a MERCK SERONO S A   (Switzerland)

^b BD Technologies   (United States)

^c BD Medical Pharmaceutical Systems   (France)

^d UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; RUBBER; BETA INTERFERON;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EQUIPMENT DESIGN; HUMAN; INJECTION PAIN; INJECTION SITE BURNING; INJECTION SITE CONTUSION; INJECTION SITE REACTION; INJECTION SITE STINGING; INTERMETHOD COMPARISON; MULTIPLE SCLEROSIS; NEEDLE; NOCICEPTION; PAIN ASSESSMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; SKIN PENETRATION; SYRINGE; ADULT; FEMALE; INSTRUMENTATION; MALE; MULTICENTER STUDY; PAIN; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON-BETA; MALE; MULTIPLE SCLEROSIS; NEEDLES; PAIN; PAIN MEASUREMENT; PATIENT SATISFACTION;

EID: 55649105874     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-8-38     Document Type: Article

References (9)

1. Vedrine L Prais W Laurent PE Raynal-Olive C Fantino M Improving needle-point sharpness in pre-fillable syringes Med Device Technol 2003, 14:32-35. 12774577
2. Bozzato GB Jaber A The thinner and finer needle (29G/5-bevel versus 27G/ 3-bevel) for interferon beta-1a subcutaneous administration leads to improved patient satisfaction 20th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). Vienna, Austria 2004, P614.
3. Hallet J Bailey C Royal Marsden Manual of Clinical Nursing Procedures Oxford: Blackwell Science 1996
4. Heft MW Gracely RH Dubner R McGrath PA A validation model for verbal description scaling of human clinical pain Pain 1980, 9:363-373. 10.1016/ 0304-3959(80)90050-0 7208081
5. Gracely RH Kwilosz DM The Descriptor Differential Scale: Applying psychophysical principles to clinical pain assessment Pain 1988, 35:279-288. 10.1016/0304-3959(88)90138-8 3226757
6. Schwid SR Thorpe J Sharief M Sandberg-Wollheim M Rammohan K Wendt J Panitch H Goodin D Li D Chang P Francis G Enhanced benefit of Increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE study Arch Neurol 2005, 62:785-792. 10.1001/ archneur.62.5.785 15883267
7. PRISMS Study Group and the University of British Columbia MS/MRI Analysis Group PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS Neurology 2001, 56:1628-1636. 11425926
8. Ebers GC the PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/ remitting multiple sclerosis Lancet 1998, 352:1498-1504. 10.1016/ S0140-6736(98)03334-0 9820297
9. Panitch H Coyle P Francis G Goodin D O'Connor P Weinshenker B The EVidence of Interferon Dose-response: European North American Comparative Efficacy (EVIDENCE) study: 48-week data Neurology 2002, 58(Suppl 3):A86.